Literature DB >> 8602623

Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.

H Wada1, Y Wakita, T Nakase, M Shimura, K Hiyoyama, S Nagaya, H Deguchi, Y Mori, T Kaneko, K Deguchi, J Fujii, H Shiku.   

Abstract

Plasma-soluble fibrin monomer (SFM) level in patients with disseminated intravascular coagulation (DIC) was significantly higher than the level in patients with pre-DIC or in non-DIC patients, and the level in patients with pre-DIC was significantly higher than that in non-DIC patients. There was no significant difference in plasma SFM levels among various diseases underlying DIC. Plasma SFM level in patients with good outcome was significantly decreased after treatment for DIC. The sensitivity of fibrin degradation products and platelet number was high for DIC, but not for pre-DIC. The sensitivity of thrombin-antithrombin III complex, plasmin-plasmin inhibitor complex, and SFM was high for both DIC and pre-DIC. The specificity of these markers was also high. Receiver operating characteristic analysis suggests that plasma SFM level could be the most useful marker for the diagnosis of both DIC and pre-DIC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8602623     DOI: 10.1002/(SICI)1096-8652(199604)51:4<255::AID-AJH1>3.0.CO;2-V

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  6 in total

1.  Atypical reduction of plasma ADAMTS13 activity by a non-IgG-type inhibitor in a patient with hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli.

Authors:  Shinya Nakayama; Shuma Hirashio; Haruka Yorishima; Toshiki Doi; Yoko Yoshida; Masanori Matsumoto; Takao Masaki
Journal:  CEN Case Rep       Date:  2019-06-08

2.  Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy.

Authors:  Shahriar Absar; Kamrun Nahar; Young Min Kwon; Fakhrul Ahsan
Journal:  Pharm Res       Date:  2013-03-07       Impact factor: 4.200

3.  Evaluation of the diagnostic performance of fibrin monomer in disseminated intravascular coagulation.

Authors:  Kyoung-Jin Park; Eui-Hoon Kwon; Hee-Jin Kim; Sun-Hee Kim
Journal:  Korean J Lab Med       Date:  2011-06-28

4.  Recent acquisitions in the pathophysiology, diagnosis and treatment of disseminated intravascular coagulation.

Authors:  Massimo Franchini; Giuseppe Lippi; Franco Manzato
Journal:  Thromb J       Date:  2006-02-21

5.  The NF-κB pathway: regulation of the instability of atherosclerotic plaques activated by Fg, Fb, and FDPs.

Authors:  Yongjun Cao; Xiaomei Zhou; Huihui Liu; Yanlin Zhang; Xiaoyan Yu; Chunfeng Liu
Journal:  Mol Cell Biochem       Date:  2013-07-10       Impact factor: 3.396

6.  Effect of disseminated intravascular coagulation on donation after citizens' death donor kidneys.

Authors:  Lu Xu; Wei Yin; Guanghui Li; Jiali Fang; Lei Zhang; Luhao Liu; Yunyi Xiong; Jialin Wu; Guanghui Pan; Junjie Ma; Zheng Chen
Journal:  Transl Androl Urol       Date:  2021-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.